Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/abstract?utm_campaign=update-langas&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_langas&_hsenc=p2ANqtz-_Zv9QsiVqaRjdXRNl3pqfSayY8K4-oslRY0XX8KybAOh2YcYG7lMpp2iC3RrUw3FXYoYeFPa-uAuhL8IJM8m8kJmx_SA&_hsmi=348848710&utm_content=348779016&utm_source=hs_email